Research team proves the efficacy of new drug against stem cells that provoke the growth of cancer

An Andalusian team of researchers led by the University of Granada has designed a drug that fights cancerogenic stem cells responsible for the onset and development of cancer, for relapse after chemotherapy, and for metastasis. The new drug, called Bozepinib, has been successfully tested in mice, and has a selective action against cancerogenic stem cells for breast and colon cancer, as well as melanoma. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *